The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer

World J Surg Oncol. 2015 Jun 4:13:194. doi: 10.1186/s12957-015-0609-3.

Abstract

Background: Recently, a preoperative systemic inflammatory response has been reported to be a prognostic factor in patients with colorectal cancer (CRC). However, the prognostic significance of a systemic inflammatory response in the early stage after surgery in patients with CRC is unknown. The aim of this retrospective study was to evaluate the prognostic significance of a postoperative systemic inflammatory response in patients with CRC.

Methods: Two hundred and fifty-four patients who underwent potentially curative surgery for stage II/III CRC were enrolled in this study. Univariate and multivariate analyses were performed to evaluate the relationship between the prognosis and clinicopathological factors, including the neutrophil-to-lymphocyte ratio (NLR) and Glasgow Prognostic Score (GPS), which were measured within two weeks before operation and at the first visit after leaving the hospital.

Results: The overall survival rates were significantly worse in the high preoperative NLR/preoperative GPS/postoperative NLR group. A multivariate analysis indicated that only preoperative GPS, postoperative NLR, and the number of lymph node metastases were independent prognostic factors for a poor survival.

Conclusions: The postoperative NLR is an independent prognostic factor in patients with CRC who underwent potentially curative surgery.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Colectomy
  • Colorectal Neoplasms / blood
  • Colorectal Neoplasms / diagnosis*
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / surgery
  • Female
  • Humans
  • Inflammation / diagnosis*
  • Inflammation / etiology
  • Leukocyte Count
  • Lymphatic Metastasis
  • Lymphocytes / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Neutrophils / pathology
  • Postoperative Complications*
  • Prognosis
  • Retrospective Studies
  • Severity of Illness Index
  • Survival Rate

Substances

  • Biomarkers